Project 1 - Cardiometabolic Injury due to VOCs
项目 1 - VOC 引起的心脏代谢损伤
基本信息
- 批准号:10693801
- 负责人:
- 金额:$ 31.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcroleinAffectAirAnimalsAreaAtherosclerosisBenzeneBile AcidsBiological MarkersBlood PlateletsBlood PressureBlood VesselsButadieneCarcinogensCardiometabolic DiseaseCardiovascular DiseasesCardiovascular systemCessation of lifeChemicalsChronicCollaborationsCommunitiesCountyDataData AnalysesDevelopmentDiabetes MellitusDisease ProgressionDoseEnvironmental ExposureEnzymesEventExposure toFarmFormaldehydeFunctional disorderGoalsHazardous ChemicalsHealthHepaticHepatocyteHepatotoxicityHospital MortalityHospitalizationHumanIndividualInjuryInsulin ResistanceKentuckyKeratinLipidsLiquid substanceLiverLiver diseasesLocationMeasurementMeasuresMetabolic DiseasesMetabolismMicroRNAsModelingMonitorNeighborhoodsParticipantPlasmaPopulationProcessRiskSerologySerumSteatohepatitisSuperfundTarget PopulationsTestingTolueneTrichloroethyleneVariantVascular DiseasesWaterWorkXylenearterial stiffnessblood glucose regulationblood pressure elevationcarcinogenicitycardiometabolic riskcardiometabolismcardiovascular disorder riskcirculating biomarkerscohortdata managementdiabetes riskdisorder riskexposed human populationfatty liver diseaseindexingland uselandfillliver biopsymonocytemortalityparticleprimary endpointresponsestem cellssuperfund sitetoxicanturinaryvascular injuryvolatile organic compoundwastewater monitoring
项目摘要
PROJECT SUMMARY
The overall goal of this project is to assess the impact of exposure to Superfund-relevant volatile
organic compounds (VOCs) on cardiometabolic disease, the underlying conditions that
contributes to diabetes, cardiovascular and liver diseases. VOCs such as trichloroethylene,
benzene, acrolein, formaldehyde, xylene and butadiene are major chemicals of concern at most
Superfund sites and extensive previous work suggests the exposure to VOC could have a variety
of adverse health effects. Nevertheless, whether exposure to VOCs at levels relevant to
neighborhood adjacent to Superfund sites could adversely affect cardiometabolic health remains
unknown. Our extensive studies with animal exposed to different VOCs suggest that chronic
exposure to low dose VOCs could increase blood pressure, inflict vascular injury, accelerate
atherosclerosis, and induce liver disease. Nevertheless, the cardiometabolic risk of VOCs has
not been evaluated and longitudinal data to interrogate exposure-response relationships are
missing. Hence, to assess CMD risk imposed by VOCs, we will test the hypothesis that exposure
to VOCs exacerbates/induces vascular and hepatic dysfunction leading to a cascade of events
that increase CMD risk. To assess the impact of VOC exposures, we will examine 1200 residents
of Jefferson County, including those who live in areas adjacent to Superfund sites such as Lee’s
Lane and Distiller Farm, as well as high VOC emission, such as the Rubbertown neighborhood.
In each participant, we will assess CMD risk by measuring arterial stiffness, marker of hepatocyte
death, as well as suite of biomarkers indicative of risk for diabetes, cardiovascular and liver
diseases. To determine population-level VOC exposure and its relationship with CMD-related
hospital admissions and mortality, we will establish a network of VOC monitors to measure VOC
levels throughout Jefferson County and monitor domestic wastewater for urinary VOC
metabolites. We will monitor wastewater every other month for 3 years, and assess the extent to
which population-level exposure estimates reflect ambient air VOC levels and individual-level
exposure (Aim 1), and how these estimates relate to population-level and individual-level CMD
risk. To obtain longitudinal data, we will examine CMD progression and determine the
association between individual-level and community-level VOC exposures with vascular and
hepatic function and other indices of cardiometabolic risk. This will help us in assessing how VOC
exposure and/or residential proximity to Superfund sites affects the risk of CMD and this
excessive risk differs from that imposed by background VOC exposures in urban neighborhood.
We expect that completion of this project will lead to the development of quantitative risk models
and rigorous estimates of the additional CMD risk attributable to residential VOC exposures.
项目摘要
本项目的总体目标是评估与超级基金相关的波动性风险敞口的影响。
有机化合物(VOCs)对心脏代谢疾病的影响,
导致糖尿病、心血管疾病和肝脏疾病。挥发性有机化合物如三氯乙烯,
苯、丙烯醛、甲醛、二甲苯和丁二烯是最受关注的主要化学品
超级基金网站和以前的大量工作表明,暴露于VOC可能有各种各样的
对健康的不良影响。尽管如此,是否暴露于VOC的相关水平,
邻近超级基金站点的社区可能会对心脏代谢健康产生不利影响
未知我们对暴露于不同VOC的动物进行的广泛研究表明,
暴露于低剂量的VOCs可增加血压,造成血管损伤,加速
动脉粥样硬化,并诱发肝脏疾病。然而,VOC的心脏代谢风险
未进行评价,询问疗效-反应关系的纵向数据
失踪了因此,为了评估VOC造成的CMD风险,我们将检验暴露
挥发性有机化合物加剧/诱导血管和肝功能障碍,导致一系列事件
这增加了CMD风险。为评估挥发性有机化合物的影响,我们会对1200名居民进行调查,
杰斐逊县,包括那些谁住在邻近地区的超级基金网站,如李的
巷和蒸馏农场,以及高挥发性有机化合物排放,如橡胶镇附近。
对于每位参与者,我们将通过测量动脉僵硬度(肝细胞标志物)来评估CMD风险
死亡,以及一套指示糖尿病、心血管和肝脏风险的生物标志物
疾病确定人群水平的VOC暴露及其与CMD相关的关系
我们会设立挥发性有机化合物监察网络,
水平在整个杰斐逊县和监测家庭废水的尿挥发性有机化合物
代谢物。我们将每隔一个月监测一次废水,持续3年,并评估废水的程度,
人口水平暴露估计反映环境空气VOC水平和个人水平
暴露量(目标1),以及这些估计与人群水平和个人水平CMD的关系
风险为了获得纵向数据,我们将检查CMD进展并确定
个人水平和社区水平的VOC暴露与血管和
肝功能和其他心脏代谢风险指标。这将有助于我们评估VOC如何
接触和/或住宅接近超级基金网站影响CMD的风险,这
过量风险不同于城市社区背景VOC暴露所造成的风险。
我们预计,该项目的完成将导致定量风险模型的开发
以及对住宅挥发性有机化合物暴露引起的额外CMD风险的严格估计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aruni Bhatnagar其他文献
Aruni Bhatnagar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aruni Bhatnagar', 18)}}的其他基金
Diversity supplement to Urban Greenness and Cardiovascular Health
城市绿化与心血管健康的多样性补充
- 批准号:
10362208 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
Diversity Supplement to Urban Greenness and Cardiovascular Health
城市绿化和心血管健康的多样性补充
- 批准号:
10598172 - 财政年份:2018
- 资助金额:
$ 31.96万 - 项目类别:
Project 1 - Cardiometabolic Injury due to VOCs
项目 1 - VOC 引起的心脏代谢损伤
- 批准号:
10354689 - 财政年份:2017
- 资助金额:
$ 31.96万 - 项目类别:
American Heart Association Tobacco Regulation and Addiction Center (A-TRAC)
美国心脏协会烟草管制和成瘾中心 (A-TRAC)
- 批准号:
8585218 - 财政年份:2013
- 资助金额:
$ 31.96万 - 项目类别:
American Heart Association Tobacco Regulation and Addiction Center (A-TRAC)
美国心脏协会烟草管制和成瘾中心 (A-TRAC)
- 批准号:
9328116 - 财政年份:2013
- 资助金额:
$ 31.96万 - 项目类别:
相似国自然基金
Acrolein调控耳蜗核神经元-胶质细胞网络参与感音神经性耳聋发病机制的研究
- 批准号:81570922
- 批准年份:2015
- 资助金额:65.0 万元
- 项目类别:面上项目
acrolein在脊髓损伤后慢性疼痛发生发展中的作用及机制研究
- 批准号:81171052
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
In vivo anti cancer natural product synthesis based on reaction with endogenous acrolein
基于与内源性丙烯醛反应的体内抗癌天然产物合成
- 批准号:
23KJ0944 - 财政年份:2023
- 资助金额:
$ 31.96万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Prodrug Strategy by Diels-Alder Reaction with Cancer-Derived Acrolein
通过与癌症衍生的丙烯醛进行第尔斯-阿尔德反应的前药策略
- 批准号:
23K17971 - 财政年份:2023
- 资助金额:
$ 31.96万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Reactivity of acrolein produced by cancer cells: Application to selective cancer therapy
癌细胞产生的丙烯醛的反应性:在选择性癌症治疗中的应用
- 批准号:
21K05269 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Resarch on prevention of cyclophosphamide cardiotocity by removing acrolein
去除丙烯醛预防环磷酰胺强心死亡的研究
- 批准号:
20K08232 - 财政年份:2020
- 资助金额:
$ 31.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
In vivo Click Reaction of Acrolein: Application to In vivo Synthetic Chemistry and Cancer Imaging
丙烯醛的体内点击反应:在体内合成化学和癌症成像中的应用
- 批准号:
18K14341 - 财政年份:2018
- 资助金额:
$ 31.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Glial activation induced by unsaturated aldehyde acrolein in diabetic retinopathy
不饱和醛丙烯醛诱导糖尿病视网膜病变中的胶质细胞活化
- 批准号:
18K09393 - 财政年份:2018
- 资助金额:
$ 31.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism of acrolein generation in diabetic retinopathy
糖尿病视网膜病变中丙烯醛的生成机制
- 批准号:
17K11442 - 财政年份:2017
- 资助金额:
$ 31.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of fluorescent probes for acrolein, a product of lipid peroxidation
脂质过氧化产物丙烯醛荧光探针的开发
- 批准号:
17H06580 - 财政年份:2017
- 资助金额:
$ 31.96万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Role of acrolein in the pathogenesis of diabetic retinopathy
丙烯醛在糖尿病视网膜病变发病机制中的作用
- 批准号:
26462657 - 财政年份:2014
- 资助金额:
$ 31.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel Treatments of Acrolein-induced Cardiotoxicity
丙烯醛引起的心脏毒性的新疗法
- 批准号:
8610016 - 财政年份:2013
- 资助金额:
$ 31.96万 - 项目类别: